TCMD
Next earnings: Aug 3, 2026 · After close
Signal
Leaning Bullish21
Price
1
Move+7.22%Strong session
Volume
1
Volume2.3× avgHeavy volume
Technical
1
RSIRSI 34Momentum negative
PRICE
Prev Close
22.43
Open
21.43
Day Range20.53 – 24.67
20.53
24.67
52W Range8.61 – 37.77
8.61
37.77
53% of range
VOLUME & SIZE
Avg Volume
429.1K
FUNDAMENTALS
P/E Ratio
27.6x
EPS (TTM)
Div Yield
No dividend
Beta
1.45
Market-like
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +17% YoY · 74% gross margin
Valuation
EXPENSIVE
P/E 28x vs ~20x sector
Health
STRONG
CR 4.2 · FCF $1.74/sh
Bullish
Key MetricsTTM
Market Cap$542.48M
Revenue TTM$343.52M
Net Income TTM$20.30M
Free Cash Flow$39.23M
Gross Margin74.0%
Net Margin5.9%
Operating Margin9.4%
Return on Equity9.7%
Return on Assets7.5%
Debt / Equity0.07
Current Ratio4.24
EPS TTM$0.90

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
4 strong1 watch1 concern
76/100
Liquidity
4.24Strong
Leverage
0.07Strong
Coverage
82.2xStrong
ROE
9.7%Watch
ROIC
7.9%Concern
Cash
$83MStrong
ANALYST COVERAGE11 analysts
HOLD
+65.4%upside to target
L $35.00
Med $40.00consensus
H $42.00
Buy
764%
Hold
218%
Sell
218%
7 Buy (64%)2 Hold (18%)2 Sell (18%)
Full report →
Stock Health
Composite Score
1 of 5 signals bullish
4/10
Technicals
RSI RangeRSI 34 — Bearish momentum
Volume
Volume FlowNeutral
~
Fundamentals
Last EarningsMissed estimates
Analyst ConsensusHold
~
LiquidityCurrent Ratio 4.24 — healthy liquidity
Upcoming Events
EEarnings ReportMay 7, 2026
Tomorrow
DEx-Dividend DateAug 4, 2026
In 90 days
PDividend PaymentAug 31, 2026
In 117 days
Technicals
Technical SetupBEARISH
Technicals →

Trend

PullbackGolden Cross · 50D leads 200D by 20.3%

-7.9% vs SMA 50 · +10.8% vs SMA 200

Momentum

RSI34.0
Momentum fading
MACD-0.79
Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$37.77+56.1%
EMA 50
$25.50+5.4%
Current
$24.19
EMA 200
$21.01-13.1%
52W Low
$8.61-64.4%
52-Week RangeMid-range
$8.6153th %ile$37.77
Squeeze SetupVolume-based
No Clear Setup

Volume distribution is neutral or leaning toward distribution. No compelling squeeze setup based on current money flow data.

20-Day Money Flow
Acc days:1
Dist days:2
Edge:+1 dist
Volume Context
Avg Vol (50D)270K
Recent Vol (5D)
166K-39%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 4 analysts
Analyst revisions:EPS↓ Revised DownRevenue↑ Revised Up

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2023
$281.5M
$278.1M$284.5M
$1.38
±1%
Moderate3
FY2024
$292.8M
$292.0M$293.5M
+4.0%$0.61-55.4%
±6%
Moderate4
FY2025
$319.7M
$319.4M$320.3M
+9.2%$0.80+29.5%
±2%
Moderate4
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryTCMD
Last 8Q
+22.6%avg beat
Beat 6 of 8 quartersMissed 2 Estimates rising
+50%
Q3'24
+17%
Q4'24
+29%
Q1'25
-86%
Q2'25
+56%
Q3'25
+125%
Q4'25
+5%
Q1'26
-14%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Analyst Activity
All ratings →
No recent activity
Piper SandlerNeutral → Overweight
Jan 5
UPGRADE
BTIGBuy
Nov 4
UPGRADE
Piper SandlerNeutral
May 6
DOWNGRADE
OppenheimerPerform
Nov 5
DOWNGRADE
Insider Activity
SEC Filings →
0 Buys/6 SellsNet Selling
Dodd Sheri LouiseCEO
$318K
Feb 24
SELL
Birkemeyer Elaine M.CFO
$223K
Feb 24
SELL
Burns KristieSr. VP Mktg & …
$181K
Feb 24
SELL
Birkemeyer Elaine M.CFO
$151K
Feb 23
SELL
Birkemeyer Elaine M.CFO
$6K
Feb 23
SELL
Dodd Sheri LouiseCEO
$416K
Feb 23
SELL
Financials

INSTITUTIONAL OWNERSHIP

1
PINNACLE ASSOCIATES LTD
327K
2
UBS Group AG
224K
3
Bank of New York Mellon Corp
151K
4
Accredited Investors Inc.
95K
5
Kopp Family Office, LLC
85K
6
BURNEY CO/
79K
7
SummerHaven Investment Management, LLC
79K
8
CWA Asset Management Group, LLC
66K
News & Activity

TCMD News

20 articles · 4h ago

About

tactile medical is one of the fastest growing companies in medical devices. as a leader in treatment options for lymphedema and venous ulcer therapies, tactile medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling . headquartered in minneapolis, minnesota, we advocate for patient access and serve tens of thousands of patients through a direct national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff.

Industry
Surgical and Medical Instrument Manufacturing
CEO
Gerald Mattys
Nicolaus WilsonSenior Vice President of Marketing & Market Access
Kristie T. BurnsSenior Vice President of Business Development
Jerry A. SauberSenior Vice President of Manufacturing, Operations, R&D
PeersHealth Care(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
TCMD
$24.19+0.00%$547M+1247.1%1500
$68.53-0.30%$13.3B+12626.1%-14525.8%1500
$90.19-1.81%$11.7B+3288.2%-4239.0%1500
$524.76-3.12%$11.5B+43205.3%-3008.0%1500
$225.41-0.29%$11.4B+6554.5%-2868.8%1500
$74.86-1.91%$10.5B51.9+2325815.3%-19.7%1500
$175.03-3.34%$10.3B28.0+1871.5%680.1%1500
Sector avg-1.54%39.9+342086.9%-3996.9%1500